Medidata Emphasizes its Study, Data, and Patient Experiences at NEXT San Francisco 2025, Pioneering the Future of Clinical Trials with AI
Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, continues its Medidata NEXT City Series today with NEXT San Francisco, uniting global experts and thought leaders in the life sciences industry to collaborate on innovation within clinical trials. Taking place at the San Francisco Airport Marriott Waterfront, the event demonstrates how the Medidata Patient, Data, and Study Experiences support the entire lifecycle of clinical trials, from initial development to final commercialization.
The Medidata Experiences, built and unified on the Medidata Platform, offer digital solutions that help sites and sponsors streamline clinical trial processes, cut costs, speed up therapy evolution, and ultimately save patients' lives. Driven by the world’s largest database of anonymized and de-identified historical clinical trial data, AI is a key component of the Medidata Platform, enabling the integration of machine learning and other advanced technologies into these experiences. During the conference’s keynote session, Medidata leadership will discuss how these Experiences are shaping tomorrow’s clinical trials. The conference also features Medidata's CEO, Anthony Costello, and Genentech’s Kim Barnholt, discussing how AI is driving the development of life-changing therapies as well as speakers from companies including Exelixis, Jazz Pharmaceuticals, PPD, and Asher Biotherapeutics.
“NEXT San Francisco is a key opportunity for global experts in the life sciences industry to connect as we continue to transform the clinical trials landscape,” said Jennifer Plumer, senior vice president, head of marketing, Medidata. “Clinical trials are becoming more complex, but through industry collaboration and our digital solutions, we can help accelerate the delivery of life-changing therapies to patients worldwide.”
Conference attendees have the opportunity to take part in panel discussions such as the Secret Sauce to Successful Trial Innovation, Strategies for Executing Complex Trials, and more. Additionally, the conference includes immersive journeys representing each of the Medidata Experiences, allowing participants to see how Medidata’s AI-powered digital solutions, such as Medidata Intelligent Trials and Medidata Clinical Data Studio, function.
To learn more about the NEXT San Francisco conference and the Medidata NEXT City Series, visit here.
Contact:
Medidata PR
Analyst Relations